Literature DB >> 11160539

Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice.

I Erlund1, E Meririnne, G Alfthan, A Aro.   

Abstract

The flavanones naringenin and hesperetin exhibit estrogenic, anticarcinogenic and antioxidative properties. Orange juice and grapefruit juice contain high amounts of these compounds, and therefore their intake from the diet can be relatively high. No data are available regarding plasma concentrations or plasma kinetics of flavanones. The objectives of this study were to develop methods allowing the analysis of naringenin and hesperetin from plasma and urine and to study their plasma kinetics and urinary excretion. We also wanted to assess whether plasma or urine flavanone concentrations can be used as biomarkers of intake. Healthy volunteers ingested orange juice (five women and three men) or grapefruit juice (two women and three men) once (8 mL/kg). Eleven blood samples and urine were collected between 0 and 24 h after juice administration. Flavanones were analyzed by HPLC with electrochemical detection. Naringenin and hesperetin were bioavailable from the studied juices, but interindividual variation in bioavailability was remarkable. The resulting plasma concentrations were comparatively high, and the peak plasma concentrations (C(max)) were 0.6 +/- 0.4 micromol/L (means +/- SD) for naringenin from orange juice and 6.0 +/- 5.4 micromol/L for naringenin from grapefruit juice. The corresponding value for hesperetin from orange juice was 2.2 +/- 1.6 micromol/L. The elimination half-lives were between 1.3 and 2.2 h, and therefore plasma concentrations reflect short-term intake. The relative urinary excretion varied depending on the flavanone source and dose and was 30.2 +/- 25.5% and 1.1 +/- 0.8% for naringenin from grapefruit juice and orange juice, respectively, and 5.3 +/- 3.1% for hesperetin from orange juice. The considerable difference in the relative urinary excretion of naringenin from the two juices was most likely caused by dose-dependent renal clearance rather than differences in bioavailability (as indicated by the similar C(max)-to-dose ratios). The results indicate that urine flavanone concentrations are not good biomarkers of dietary intake. We conclude that because of the relatively high concentrations of flavanones in plasma after ingestion of orange juice or grapefruit juice, considerable health effects could ensue in individuals consuming them regularly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160539     DOI: 10.1093/jn/131.2.235

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  80 in total

1.  Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

Authors:  Wenjie Jessie Lu; Valentina Ferlito; Cong Xu; David Alastair Flockhart; Salvatore Caccamese
Journal:  Chirality       Date:  2011-09-22       Impact factor: 2.437

2.  Naringenin modulates skeletal muscle differentiation via estrogen receptor α and β signal pathway regulation.

Authors:  Marco Pellegrini; Pamela Bulzomi; Paola Galluzzo; Marco Lecis; Stefano Leone; Valentina Pallottini; Maria Marino
Journal:  Genes Nutr       Date:  2014-08-26       Impact factor: 5.523

3.  Bioavailability and antioxidant effects of orange juice components in humans.

Authors:  Adrian A Franke; Robert V Cooney; Susanne M Henning; Laurie J Custer
Journal:  J Agric Food Chem       Date:  2005-06-29       Impact factor: 5.279

4.  Quercetin blocks airway epithelial cell chemokine expression.

Authors:  Suparna Nanua; Suzanna M Zick; Juan E Andrade; Umadevi S Sajjan; John R Burgess; Nicholas W Lukacs; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 5.  Interindividual differences in phytochemical metabolism and disposition.

Authors:  Johanna W Lampe; Jyh-Lurn Chang
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

6.  Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial.

Authors:  Candida J Rebello; Robbie A Beyl; Juan J L Lertora; Frank L Greenway; Eric Ravussin; David M Ribnicky; Alexander Poulev; Brandon J Kennedy; Hector F Castro; Shawn R Campagna; Ann A Coulter; Leanne M Redman
Journal:  Diabetes Obes Metab       Date:  2019-09-30       Impact factor: 6.577

7.  Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.

Authors:  Huan Wang; Hong-Fei Wang; Hao Zhang; Chen Wang; Yu-Fang Chen; Rong Ma; Ji-Zhou Xiang; Xin-Ling Du; Qiang Tang
Journal:  Acta Pharmacol Sin       Date:  2016-10-03       Impact factor: 6.150

8.  The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells.

Authors:  Brian Morin; LaNita A Nichols; Katherine M Zalasky; J Wade Davis; John A Manthey; Lené J Holland
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

9.  Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.

Authors:  Jia-Yu Ke; Rachel M Cole; Essam M Hamad; Yung-Hsuan Hsiao; Bradley M Cotten; Kimerly A Powell; Martha A Belury
Journal:  Mol Nutr Food Res       Date:  2015-12-28       Impact factor: 5.914

10.  Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.

Authors:  Chenlin Shen; Zhengyue Qian; Ruonan Chen; Xiaoming Meng; Tingting Hu; Zhaolin Chen; Yangyang Li; Cheng Huang; Chaojie Hu; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.